RESECTED PANCREATIC ADENOCARCINOMA
Clinical trials for RESECTED PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTED PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RESECTED PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep pancreatic cancer away after surgery
Disease control Recruiting nowThis study tests a new drug called daraxonrasib in people with pancreatic cancer who have already had surgery and chemotherapy. The goal is to see if taking the drug can delay or prevent the cancer from returning compared to just watching and waiting. About 500 adults will be ran…
Matched conditions: RESECTED PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Tailored chemo after surgery could boost pancreatic cancer survival
Disease control Recruiting nowThis study tests whether giving different chemotherapy drugs after pancreatic cancer surgery, based on how much tumor remains, can improve survival. About 390 patients who received chemo before surgery will be randomly assigned to one of two drug regimens. The goal is to reduce c…
Matched conditions: RESECTED PANCREATIC ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC